FDA, COVID-19 pandemic and vaccine
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over the age of 65 years and for all persons above the age of 6 months with
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
17hon MSN
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.
Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on the Food and Drug Administration's (FDA's) decision this week to issue new, more restrictive, COVID-19 vaccine recommendations via an opinion piece in the New England Journal of Medicine (NEJM).
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.